Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment

Atherosclerosis and its manifestations namely cardiovascular diseases (CVD) are still the leading cause of morbidity and mortality worldwide. Although intensified interventions have been applied, the residual cardiovascular (CV) risks are still very high. Lipoprotein-associated phospholipase A2 (Lp-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Anping, Zheng, Dongdan, Qiu, Ruofeng, Mai, Weiyi, Zhou, Yingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2013
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810239/
https://www.ncbi.nlm.nih.gov/pubmed/23478277
http://dx.doi.org/10.3233/DMA-130976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810239/
https://www.ncbi.nlm.nih.gov/pubmed/23478277
http://dx.doi.org/10.3233/DMA-130976

Ejemplares similares